Plasma transforming growth factor-β1 level in patients with severe community-acquired pneumonia and association with disease severity

Journal of the Formosan Medical Association

Volumn 108, Issue 1, 2009, Pages 20-27

  Wu, Huang Pin ^a,b   Chen, Chian Kuang ^a,b   Chung, Kong ^a,b   Jiang, Bor Yiing ^a,b   Yu, Teng Jen ^a,b   Chuang, Duen Yau ^c  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Community acquired pneumonia; Cytokine; Disease severity; Interleukin 10; Mortality; Transforming growth factor

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA1;

AGED; APACHE; ARTICLE; BLOOD ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EMERGENCY WARD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT TRANSPORT; PREDICTION; PROGNOSIS; PSEUDOMONAS AERUGINOSA; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SEPTIC SHOCK; SURVIVOR;

EID: 60149087743     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-6646(09)60028-0     Document Type: Article

References (29)

1. van der Eerden MM, de Graaff CS, Bronsveld W, et al. Prospective evaluation of pneumonia severity index in hospitalised patients with community-acquired pneumonia. Respir Med 2004;98:872-8.
2. Gursel G, Demirtas S. Value of APACHE II, SOFA and CPIS scores in predicting prognosis in patients with ventilator-associated pneumonia. Respiration 2006;73:503-8.
3. Tejera A, Santolaria F, Diez ML, et al. Prognosis of community acquired pneumonia (CAP): value of triggering receptor expressed on myeloid cells-1 (TREM-1) and other mediators of the inflammatory response. Cytokine 2007; 38:117-23.
4. Menendez R, Cavalcanti M, Reyes S, et al. Markers of treatment failure in hospitalized community-acquired pneumonia. Thorax 2008;63:447-52.
5. Christ-Crain M, Muller B. Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators. Eur Respir J 2007;30:556-73.
6. Gibot S, Kolopp-Sarda MN, Bene MC, et al. Plasma level of a triggering receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected sepsis. Ann Intern Med 2004;141:9-15.
7. Chao WC, Wang CH, Chan MC, et al. Predictive value of serial measurements of sTREM-1 in the treatment response of patients with community-acquired pneumonia. J Formos Med Assoc 2007;106:187-95.
8. Wu CL, Chan MC, Chang GC, et al. Etiology and cytokine expression in patients requiring mechanical ventilation due to severe community-acquired pneumonia. J Formos Med Assoc 2006;105:49-55.
9. Opal SM, DePalo VA. Anti-inflammatory cytokines. Chest 2000;117:1162-72.
10. Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality initiative (ADQI) Group. Crit Care 2004;8: R204-12.
11. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-74.
12. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003;31:1250-6.
13. Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818-29.
14. Bosio CM, Bielefeldt-Ohmann H, Belisle JT. Active suppression of the pulmonary immune response by Francisella tularensis Schu4. J Immunol 2007;178:4538-47.
15. Cui X, Zeni F, Vodovitz Y, et al. TGF-beta1 increases microbial clearance but worsens lung injury during Escherichia coli pneumonia in rats. Cytokine 2003;24:115-27.
16. Afzali B, Lombardi G, Lechier RI, et al. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol 2007;148:32-46.
17. Mizgerd JP. Acute lower respiratory tract infection. N Engl J Med 2008;358:716-27.
18. Kolls JK, Linden A. Interleukin-17 family members and inflammation. Immunity 2004;21:467-76.
19. Rudge G, Gleeson PA, van Driel IR. Control of immune responses by immunoregulatory T cells. Arch Immunol Ther Exp (Warsz) 2006;54:381-91.
20. Hougardy JM, Place S, Hildebrand M, et al. Regulatory T cells depress immune responses to protective antigens in active tuberculosis. Am J Respir Crit Care Med 2007;176:409-16.
21. Glynn P, Coakley R, Kilgallen I, et al. Circulating interleukin 6 and interleukin 10 in community acquired pneumonia. Thorax 1999;54:51-5.
22. Gallagher PM, Lowe G, Fitzgerald T, et al. Association of IL-10 polymorphism with severity of illness in community acquired pneumonia. Thorax 2003;58:154-6.
23. Dinarello CA. Proinflammatory cytokines. Chest 2000; 118:503-8.
24. Pinsky MR, Vincent JL, Deviere J, et al. Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 1993;103:565-75.
25. Calandra T, Gerain J, Heumann D, et al. High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. The Swiss-Dutch J5 Immunoglobulin Study Group. Am J Med 1991;91:23-9.
26. Sun K, Salmon SL, Lotz SA, et al. Interleukin-12 promotes gamma interferon-dependent neutrophil recruitment in the lung and improves protection against respiratory Streptococcus pneumoniae infection. Infect Immun 2007; 75:1196-202.
27. Salvatore CM, Fonseca-Aten M, Katz-Gaynor K, et al. Respiratory tract infection with Mycoplasma pneumoniae in interleukin-12 knockout mice results in improved bacterial clearance and reduced pulmonary inflammation. Infect Immun 2007;75:236-42.
28. Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001;163:1730-54.
29. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171:388-416.